All Marketing authorization holders of medicine are hereby informed that 72nd Medicines Evaluation Committee held on 22nd November 2022 recommended not to register new products of Ketorolac Tromethamine Orally Disintegrating Tablets and not to renew or issue import license for existing Ketorolac Tromethamine Orally Disintegrating Tablets.

(Date : 18 April 2023)

‍